| Institution: | 1. Leukemia Department, M.D. Anderson Cancer Center, Houston, TX;2. Staten Island University Hospital, New York, NY;1. Beta-Cell Biochemistry Laboratory, John D. Dingell VA Medical Center, and Department of Pharmaceutical Sciences, Wayne State University, Detroit, MI 48201, USA;2. Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico Medical School Campus, Post Office Box 365067, San Juan, PR 00936-5067, USA;3. School of Biomedical Sciences, Curtin Health Sciences Innovation Research Institute, Curtin University, Perth, WA 6845, Australia;1. Service d’hématologie, CHU de Besançon, 1, boulevard Fleming, 25030 Besançon cedex, France;2. Inserm UMR1098, bâtiment Inserm, 20, rue Françoise-Dolto, 25000 Besançon, France;3. SFR FED 4234, bâtiment Inserm, université de Franche-Comté, 20, rue Françoise-Dolto, 25000 Besançon, France;4. Plateforme de biomonitoring, EFS Bourgogne Franche-Comté, 2, boulevard Fleming, 25020 Besançon cedex, France;5. Centre d’investigation clinique en biothérapies 506, CHU de Besançon, 1, boulevard Fleming, 25030 Besançon cedex, France;6. Activité d’ingénierie et de thérapie cellulaire, EFS Bourgogne Franche-Comté, 2, boulevard Fleming, 25020 Besançon cedex, France;7. Laboratoire HLA, EFS Bourgogne Franche-Comté, 2, boulevard Fleming, 25020 Besançon cedex, France;8. Service de bactériologie, CHU de Besançon, 1, boulevard Fleming, 250030 Besançon cedex, France;3. From the Institute of Pharmacology and Toxicology and;4. the Core Unit Mass Spectrometry and Proteomics, Medical Faculty, Ulm University, 89081 Ulm, Germany,;5. the Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69121 Heidelberg, Germany, and;6. the Diaxonhit, 63–65 Boulevard Masséna, 75013 Paris, France;1. Massachusetts General Hospital, Zero Emerson Place, Suite 118, Boston, MA 02114, USA;2. Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA |
